The best approach for surgeons to identify malnourished cancer patients before they have a cancer operation may be related to the cancer type, according to an article published in the Journal of the American College of Surgeons.
Last week, Richard Pazdur was named to the position of director of FDA’s Center for Drug Evaluation and Research. Much has been written about how Pazdur, with nearly a three-decade long career at the agency, represents a stabilizing choice for FDA as it faces inner and outer turmoil.
